The peer-reviewed literature does not support that framing
Tablets remain stable for 24 months
Patients obtaining BPC-157 through compounding pharmacies or gray-market sources face variable purity, potency, and concentration
Reporting Adverse Events or Safety Concerns If you experience or suspect an adverse event, contamination, or quality issue with this product, report it immediately to: Hospira Pfizer: Manufacturer contact information available on the product vial FDA MedWatch: 1-888-SAFEMED (1-888-723-3633) or online at fda.gov/medwatch Poison Control: 1-800-222-1222 (for toxicology guidance) Your institutional pharmacovigilance system: If you work for a hospital, clinic, or healthcare institution Regulatory Compliance By purchasing and using this product, you agree to comply with all applicable FDA regulations, state pharmacy laws, and professional licensing requirements
A phase 2 human trial was completed in 2009 and never published
It may serve this purpose in Alpha BRAIN, too
